Scientific Publications

Search by Keyword(s)
Found 4 results

Filters: Author is Majumder, PK  [Clear All Filters]

Search Results

  • Showing 1-4 of 4 Results
2015
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.Majumder, B., Baraneedharan U., Thiyagarajan S., Radhakrishnan P., Narasimhan H., Dhandapani M., Brijwani N., Pinto DD, Prasath A., Shanthappa BU, Thayakumar A., Surendran R., Babu GK, Shenoy AM, Kuriakose MA, Bergthold G., Horowitz P., Loda M., Beroukhim R., Agarwal S., et al. Nature communications, 2015/02/27, Volume 6, p.6169, (2015) Read More / View Supplemental Materials
Abstract
2007
Identification of prostate cancer modifier pathways using parental strain expression mapping.Xu, Q., Majumder PK, Ross K., Shim Y., Golub T. R., Loda M., and Sellers WR Proceedings of the National Academy of Sciences of the United States of America, 2007/11/06, Volume 104, Issue 45, p.17771-6, (2007) Read More / View Supplemental Materials
Abstract
2004
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.Berger, R., Febbo PG, Majumder PK, Zhao JJ, Mukherjee S., Signoretti S., Campbell KT, Sellers WR, Roberts TM, Loda M., Golub T. R., and Hahn WC Cancer research, 2004/12/15, Volume 64, Issue 24, p.8867-75, (2004) Read More / View Supplemental Materials
Abstract
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.Majumder, PK, Febbo PG, Bikoff R., Berger R., Xue Q., McMahon LM, Manola J., Brugarolas J., McDonnell TJ, Golub T. R., Loda M., Lane HA, and Sellers WR Nature medicine, 2004/06/01, Volume 10, Issue 6, p.594-601, (2004) Read More / View Supplemental Materials
Abstract
  • Showing 1-4 of 4 Results